Viatris (VTRS) Amortization of Deferred Charges (2020)

Viatris (VTRS) posted quarterly Amortization of Deferred Charges of $2.8 million for Q3 2020.

Viatris (VTRS) Amortization of Deferred Charges (2020) Analysis & Trends

Viatris' Amortization of Deferred Charges history runs 1 years deep, the most recent figure standing at $2.8 million for Q3 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	43.89 Bn	42.93 Bn	-
2	Teva Pharmaceutical Industries	42.98 Bn	39.33 Bn	2.15 Bn
3	Zoetis	31.54 Bn	29.86 Bn	1.05 Bn
4	Takeda Pharmaceutical	28.61 Bn	22.81 Bn	5.10 Bn
5	United Therapeutics	22.15 Bn	19.48 Bn	683.80 Mn
6	Viatris	18.75 Bn	17.86 Bn	1.46 Bn
7	Neurocrine Biosciences	15.56 Bn	15.17 Bn	935.80 Mn
8	Elanco Animal Health	11.74 Bn	11.21 Bn	798.00 Mn
9	Dr Reddys Laboratories	10.11 Bn	9.95 Bn	-
10	Alkermes	8.11 Bn	7.46 Bn	397.90 Mn

Download Data

Date	Value
Sep 27, 2020	2.80 Mn
Sep 27, 2020	2.80 Mn